CAT and Alzheimer disease: The presented results offer preliminary evidence of the involvement of SGLT in the regulation of Aβ 1-42 expression and catalase activity in the gastrointestinal tract and indicate that redox dyshomeostasis in the STZ-icv model of AD might be abolished with SGLTIs.